Aciphex Related Clinical Trials
A Relative Bioavailability Study of Rabeprazole Sodium Administered With Different Dosing Vehicles (Food, Other) in Healthy Adult Volunteers [Recruiting]
Fed Study of Rabeprazole Sodium Tablets 20 mg and Aciphex® Tablets 20 mg [Completed]
Food Study of Rabeprazole Sodium Delayed-Release Tablets 20 mg to Aciphex® Tablets 20 mg [Completed]
A Study to Evaluate the Effect on 24-hour, Intragastric pH of RAB ER 50-mg Capsules Compared With Esomeprazole (Nexium) 40 mg Capsules and Rabeprazole (Aciphex) 20-mg Tablets [Not yet recruiting]
Fasting Study of Rabeprazole Sodium Delayed-Release Tablets 20 mg to Aciphex® Delayed-Release Tablets 20 mg [Completed]
Comparison of Oral Rabeprazole vs. iv Omeprazole in Mild to Moderate Nonvariceal Upper Gastrointestinal Bleeding [Recruiting]
Effects of Oral Rabeprazole on the Prevention of Ulcer Bleeding Following Endoscopic Mucosal Resection [Recruiting]
Clinical Pharmacology Study of 5 mg , 10 mg, 20 mg and 40 mg Tablets of E3810 in Healthy Adult Japanese Male [Not yet recruiting]
Comparison of Ulcer Healing in Patients Taking Rabeprazole With Different Antiplatelets [Recruiting]
A Trial of Standard vs Half Dose Rabeprazole, Clarithromycin, Metronidazole and Amoxicillin in the Treatment of Helicobacter Pylori Infection [Recruiting]
A Study of Single and Multiple Doses of Rabeprazole in Pediatric Patients With Gastroesophageal Reflux Disease (GERD) 1 to 11 Months Old, Inclusive [Recruiting]
To Evaluate the Safety and Efficacy of Rabeprazole in Infants With Gastroesophageal Erosive Reflux Disease (GERD) [Recruiting]
Double-dose Rabeprazole Accelerates and Sustains the Control of Symptoms in Patients With NERD [Not yet recruiting]
Rabeprazole Based Sequential-Concommitant Hybrid Therapies for H. Pylori Infections [Recruiting]
A Study of Rabeprazole for Prevention of Non Steroidal Anti-inflammatory Drug (NSAID)-Associated Dyspepsia and Gastroduodenal Injury [Recruiting]
A Study of Rabeprazole and Pantoprazole on Stomach Acid and Esophageal Acid Exposure in Patients With Gastroesophageal Reflux Disease (GERD) and a History of Nighttime Heartburn [Completed]
Prospective Double-blinded Randomized Controlled Trial of 12-weeks High Dose Rabeprazole (Pariet) in the Treatment of Reflux Laryngitis in Chinese Patients [Recruiting]
A Pharmacokinetics (Blood Levels), Pharmacodynamics (How the Drug Acts on the Body) and Safety Study Dosing of Rabeprazole in New Borns With Gastroesophageal Reflux Disease (GERD). [Recruiting]
A Study of E3810 for Japanese Subjects With Functional Dyspepsia [Recruiting]
A Study of the Safety and Effectiveness of Rabeprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Pediatric Patients. [Recruiting]
Double-blind Comparative Study of E3810 Tablets (10 or 20 mg b.i.d.) to Evaluate Efficacy and Safety in Patients With Refractory Reflux Esophagitis [Recruiting]
Open Label Study Evaluating Different Dosing Regimens of Rabeprazole in Gastro-Esophageal Reflux Disease (GERD) Patients With Night-Time Heartburn Symptoms. [Completed]
Rabeprazole in Subjects With Gastroesophageal Reflux Disease (GERD) [Completed]
Compare How Effective Standard Dose Proton Pump Inhibitor (PPI) and Low Dose Tricyclic Antidepressant and Double Dose PPI to Standard Dose PPI and Placebo [Recruiting]
Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD) [Recruiting]
Rabeprazole Extended-Release, 50 mg, Versus Esomeprazole, 40 mg, for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD) [Recruiting]
A Comparative Study on the Efficacy and Safety of E3810 in Patients With Non-Erosive Gastroesophageal Reflux Disease [Completed]
Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD) [Recruiting]
Influence of Rabeprazole on the Magnitude of the Antiplatelet Action of Clopidogrel [Not yet recruiting]
Rabeprazole Protection of Aspirin Induced Gastric Damage. [Completed]
To Assess the Efficacy of Esomeprazole 20mg Once Daily in Subjects Who Still Had Heartburn After Receiving Rabeprazole [Not yet recruiting]
Rabeprazole Extended Release 50 mg Versus Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD) [Recruiting]
Study of the Safety and Effectiveness of Rabeprazole in Treatment of Helicobacter Pylori Infection in Adults. [Completed]
A Study of Efficacy and Safety of "on-Demand" Maintenance Therapy With Rabeprazole in Patients With Non-Erosive Reflux Disease (NERD) [Completed]
A Study of the Safety of Rabeprazole Administered to Adults With Gastroesophageal Reflux Disease (GERD) [Completed]
A Drug-Drug Interaction Study of the Effect of Rabeprazole, Itraconazole or Fluconazole on the Pharmacokinetics of Vismodegib [Not yet recruiting]
Safety of Rabeprazole in Patients Under Multiple Treatments. [Active, not recruiting]
A Study of E3810 With Pre- and Post-Treatment pH Monitoring in Patients With Non-Erosive Gastroesophageal Reflux Disease [Completed]
E3810-A001-312: Efficacy and Safety of 10 Mg Rabeprazole for Treating Heartburn in Frequent Sufferers [Active, not recruiting]
E3810-A001-313: Efficacy and Safety of 10 Mg Rabeprazole for Treating Heartburn in Frequent Sufferers [Active, not recruiting]
A Study to Monitor Intragastric pH in Patients Taking Rabeprazole vs. Patients Taking Pantoprazole [Completed]
Treatment of Gastroesophageal Reflux Disease in 12-16 Year Old Patients With Rabeprazole [Active, not recruiting]
Rabeprazole 20 mg Maintenance Intermittent Therapy Following Acute Treatment in Patients With Symptomatic Gastroesophageal Reflux Disease [Active, not recruiting]
Sleep Disorders and Gastroesophageal Reflux Disease (GERD) [Completed]
Effects of Gastric pH on the Pharmacokinetics of Dasatinib [Recruiting]
Effects of Gastric pH on the Pharmacokinetics of Atazanavir [Recruiting]
A Pharmacokinetic and Safety Study of Single and Multiple Doses of Rabreprazole in Pediatric Patients With Gastroesophageal Reflux Disease (GERD) 1 to 11 Years Old, Inclusive [Recruiting]
CYP2C19 Genetic Polymorphism on the Accuracy of Proton-Pump Inhibitor Testing [Recruiting]
A Comparative Study of Proton-Pump Inhibitor Tests for Chinese Reflux Patients in Relation to the CYP2C19 Genotypes [Completed]
A Study to Compare the Number of Patients With Gastro-Oesophageal Reflux Disease (GORD) Achieving Heartburn and Regurgitation Symptom Resolution After Treatment With Either Rabeprazole Sodium 20mg, Esomeprazole 20mg or Esomeperazole 40m [Recruiting]
Comparison of the Nighttime Effects of Two Different Drugs on Subjects With GERD [Completed]
Laryngopharyngeal Reflux and Proton Pump Inhibitor (PPI) Treatment [Completed]
Prognostic Study of Gastric MALT Lymphoma After Eradication of Helicobacter Pylori [Recruiting]
Increased Re-eradication Rate of Helicobacter Pylori by Adding N-acetylcystein or Metronidazole to the Triple Therapy [Recruiting]
Study of Changes in Reflux Symptoms and Reflux Finding Score According to Rabeprazole Treatment Period. [Not yet recruiting]
Evaluate the Effects on Asthma Control of Rabeprazole Given Twice Daily in Subjects With Asthma. [Completed]
Prevention of Recurrent Gastric or Duodenal Ulcers Caused by Low-dose Aspirin With Rabeprazole (E3810) Treatment (Planetarium Study) [Recruiting]
Long-term Prevention of Recurrent Gastric or Duodenal Ulcers Caused by Low-dose Aspirin With Rabeprazole (E3810) Treatment (Planetarium Study) [Recruiting]
To Assess the Efficacy of Esomeprazole 40 mg Once Daily in Subjects Who Still Had Heartburn After Receiving Rabeprazole [Recruiting]
Second Line Therapy for the Cure of Helicobacter Pylori (H. Pylori) Infection [Recruiting]
Improvement in Bronchial Asthma in Patients With Extraesophageal Reflux After Acid Suppression [Recruiting]
The Effect of Proton Pump Inhibitors on Calcium and Bone Metabolism [Recruiting]
Cardio-cerebrovascular Disease and Aspirin Ulcer Relapse Evaluation [Recruiting]
Trial of Electrosurgical Incision Versus Bougie Dilation of Symptomatic Lower Esophageal (Schatzki's) Rings [Completed]
Histamine-2 Receptor Antagonist Versus Proton-Pump Inhibitor for the Prevention of Ulcer Bleeding Associated With Low-dose Aspirin in Patients With Very High Ulcer Risk [Recruiting]
Endoscopic Fundoplication Versus Proton Pump Inhibitors for GERD Treatment [Recruiting]
Role of Pain Modulation in Gastroesophageal Reflux Disease (GERD) Patients Who Failed Standard Dose Proton Pump Inhibitors (PPI) [Not yet recruiting]
Efficacy of High Dose Dual Therapy, Sequential Therapy and Triple Therapy in H. Pylori Eradication [Recruiting]
A Study of the Use of High-dose Proton Pump Inhibitor for the Treatment of Gastro-oesophageal Reflux Related Non-cardiac Chest Pain - a Randomized Double-blind Placebo-controlled Study [Recruiting]
The Role of CYP2C19 on the Eradication of H. Pylori Infection:Implication of PK/PD Relationships [Active, not recruiting]
A Double-Blind, Comparative Study in Patients With Gastric Ulcer to Evaluate the Efficacy of Combination Use of E0671 and Rabeprazole Sodium [Recruiting]
The Proton Pump Inhibitor (PPI) Test for the Extraesophageal Manifestation of GERD [Recruiting]
Efficacy of 10-day Concomitant Regimen Versus High Dose Dual Therapy in Anti-Helicobacter Pylori Rescue Therapy [Recruiting]
Importance of Cytokines in Peptic Ulcer Disease: Implications for Treatment [Recruiting]
Post-Nasal Drainage as an Extraesophageal Manifestation of Reflux [Active, not recruiting]
Influence of Hygiene-Dietetic Habits and Treatment Adherence on the Effectiveness of the Gastroesophageal Reflux Illness Treatment With Rabeprazol. [Active, not recruiting]
|
